Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Phentermine,Topiramate
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase IV
Sponsor : Mayo Clinic
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : QSIVA is a combination of phentermine, a sympathomimetic amine anorectic and topiramate extended-release, an antiepileptic drug. It is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adul...
Brand Name : Qsiva
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 17, 2023
Lead Product(s) : Phentermine,Topiramate
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase IV
Sponsor : Mayo Clinic
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?